Philab Holdings (PHS:DNA) ROCE % : -24.80% (As of Sep. 2019)

View and export this data going back to 2009. Start your Free Trial

What is Philab Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Philab Holdings's annualized ROCE % for the quarter that ended in Sep. 2019 was -24.80%.

Philab Holdings ROCE % Historical Data

The historical data trend for Philab Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philab Holdings ROCE % Chart

Philab Holdings Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

ROCE %

Get a 7-Day Free Trial

45.51

-15.61

-4.33

-39.96

-20.56

Philab Holdings Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
ROCE %	Get a 7-Day Free Trial															-11.45	-93.20	-29.29	-18.85	-24.80

Philab Holdings ROCE % Calculation

Philab Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2018 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2018 )		(A: Dec. 2017 )		(A: Dec. 2018 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2018 )		(A: Dec. 2017 )		(A: Dec. 2018 )
	=	-118.551	/	( ( (2020.72 - 1119.278)	+	(1980.621 - 1729.024) )	/ 2 )
	=	-118.551	/	( (901.442	+	251.597)	/ 2 )
	=	-118.551	/	576.5195
	=	-20.56 %

Philab Holdings's ROCE % of for the quarter that ended in Sep. 2019 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2019 )		(Q: Jun. 2019 )		(Q: Sep. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2019 )		(Q: Jun. 2019 )		(Q: Sep. 2019 )
	=	-40.412	/	( ( (1941.338 - 1761.611)	+	(1931.955 - 1785.744) )	/ 2 )
	=	-40.412	/	( ( 179.727	+	146.211 )	/ 2 )
	=	-40.412	/	162.969
	=	-24.80 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2019) EBIT data.

Philab Holdings (PHS:DNA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Philab Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Philab Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Philab Holdings (PHS:DNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Philab Holdings Corp (PHS:DNA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1128, Fort Bonifacio, 8th Floor, Global City, Taguig, PHL, 1634

Website

http://www.philab.com

Philab Holdings Corp operates in the healthcare sector. The company is engaged in supplying and distributing life science equipment to healthcare, pharmaceutical, semiconductor, and food-beverage industries.